SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Current perspectives in transfusion‐transmitted infectious diseases: emerging and re‐emerging infections
1 references·7 citing·30 second hop
Current perspectives in transfusion‐transmitted infectious diseases: emerging and re‐emerging infections (2014)Current perspectives in transfusion‐trans…Emerging infectious disease agents and their potential threat to transfusion safety (2009)Emerging infectious disease a…Blood Transfusion-Associated Infections in the Twenty-First Century: New Challenges (2020)Blood Transfusion-Associated …Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting. (2019)Pathogen reduction of blood c…Transfusion-Transmitted Infections: an Update on Product Screening, Diagnostic Techniques, and the Path Ahead (2018)Transfusion-Transmitted Infec…Metagenomics in pooled plasma, with identification of potential emerging infectious pathogens (2017)Metagenomics in pooled plasma…Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk (2017)Emerging Infectious Diseases …Viral metagenomics and blood safety (2016)Viral metagenomics and blood …Impact of using different blood donor subpopulations and models on the estimation of transfusion transmission residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in Z imbabwe (2016)Impact of using different blo…The Risk of Transfusion-Transmitted Viral Infections (1996)Modern Industrial Statistics: Design and Control of Quality and Reliability (1999)The risk of transfusion‐transmitted infections in sub‐Saharan Africa (2009)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Severe acute respiratory syndrome coronavirus‐2: implications for blood safety and sufficiency (2020)Severe Acute Respiratory Syndrome Coronavirus 2 and Blood Safety: An Updated Review (2022)Challenges for the maintaining the microbiological safety of the UK blood supply (2023)Current viral risks of blood and blood products (2000)Knowledge, attitudes and clinical practice of blood products prescribers in Niamey (2016)Metagenomic analysis of potential pathogens from blood donors in Guangzhou, China (2019)Standards for blood banks and transfusion services. (1977)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Blood Donation and COVID-19: Reconsidering the 3-Month Deferral Policy for Gay, Bisexual, Transgender, and Other Men Who Have Sex With Men (2020)Follow‐up program for blood donors with unconfirmed screening results reveals a high false‐positive rate in Dalian, China (2020)The Prevalence of Transfusion Transmitted Infections among Blood Donors in Pakistan: A Retrospective Study (2021)Reducing the risk of infection from plasma products: specific preventative strategies (2000)Assessing risks of infection with herpes viruses during transfusion of donor blood and its components (2020)Assessing risks of infection with herpes viruses during transfusion of donor blood and its components (2020)Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction (2022)Seroprevalence of transfusion transmitted infection among blood donors at Jijiga blood bank, Eastern Ethiopia: retrospective 4 years study (2016)Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation (2018)Transfusion Transmissible Infections in Blood Donors in the Province of Bié, Angola, during a 15-Year Follow-Up, Imply the Need for Pathogen Reduction Technologies (2021)Patterns of Hepatitis B, Hepatitis C and HIV Among Blood Donors in Samtah-Jazan Region (2022)Regulatory Compliance and Managerial Control in the Hemotherapy and Blood Bank Program of EsSalud Huancayo (2024)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)Prevention of transfusion-transmitted infections (2019)Post-donation information management (2021)Prevalence of transfusion-transmitted infections in hospitalized patients before transfusion and volunteer blood donors in Zhejiang Province, China. (2024)
this work references cited by second hop

References

  • 2009Emerging infectious disease agents and their potential threat to transfusion safety427 cited

Cited by

  • 2018Transfusion-Transmitted Infections: an Update on Product Screening, Diagnostic Techniques, and the Path Ahead56 cited
  • 2020Blood Transfusion-Associated Infections in the Twenty-First Century: New Challenges43 cited
  • 2016Viral metagenomics and blood safety33 cited
  • 2017Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk33 cited
  • 2019Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting.28 cited
  • 2017Metagenomics in pooled plasma, with identification of potential emerging infectious pathogens12 cited
  • 2016Impact of using different blood donor subpopulations and models on the estimation of transfusion transmission residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in Z imbabwe8 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work